Inhaled amphotericin B lipid complex for prophylaxis against COVID-19-associated invasive pulmonary aspergillosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00134-021-06603-y.pdf
Reference5 articles.
1. Prattes J, Wauters J, Giacobbe DR et al (2021) Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry. Intensive Care Med. https://doi.org/10.1007/s00134-021-06471-6
2. Koehler P, Bassetti M, Chakrabarti A et al (2021) Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis 21:e149–e162. https://doi.org/10.1016/S1473-3099(20)30847-1
3. Verweij PE, Brüggemann RJM, Azoulay E et al (2021) Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med 47:819–834. https://doi.org/10.1007/s00134-021-06449-4
4. Fournel I, Sautour M, Lafon I et al (2010) Airborne aspergillus contamination during hospital construction works: efficacy of protective measures. Am J Infect Control 38:189–194. https://doi.org/10.1016/j.ajic.2009.07.011
5. Verweij PE, Rijnders BJA, Brüggemann RJM et al (2020) Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med 46:1524–1535. https://doi.org/10.1007/s00134-020-06091-6
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients;The Lancet Respiratory Medicine;2024-09
2. Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease;Clinical Microbiology Reviews;2024-06-13
3. Study protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of covid-19-associated pulmonary aspergillosis;Contemporary Clinical Trials Communications;2024-06
4. Severe mold fungal infections in critically ill patients with COVID-19;Future Microbiology;2024-05-31
5. Use of nebulized liposomal amphotericin B and posaconazole as antifungal prophylaxis in patients with severe SARS-CoV2 infection in intensive care unit;Infection;2024-03-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3